February 26, 2024

Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The wealth of data generated by continuous glucose monitoring (CGM) provides new opportunities for revealing heterogeneities in patients with type 2 diabetes mellitus (T2DM). We aimed to develop a method using CGM data to discover T2DM subtypes and investigate their relationship with clinical phenotypes and microvascular complications.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Shao et al. (Mon,) studied this question.

synapsesocial.com/papers/68e778d3b6db6435876ed5c2 https://doi.org/https://doi.org/10.1111/dom.15512

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 20452021 · 9,803 citations
2Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial2016 · 633 citations
3Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies2015 · 53 citations
4Influencing factors of glycemic variability in hospitalized type 2 diabetes patients with insulin therapy2017 · 12 citations
5Type 2 diabetes2017 · 2,476 citations

Preguntar a la IA

Me gusta

Guardar